ArticleInvestigational new drugs2012

Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients.

Yutaka Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.